These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 5350784)

  • 21. Supersensitivity of the isolated nictitating membrane of the cat to sympathomimetic amines after impairment of the intraneuronal mechanisms of inactivation.
    Trendelenburg U
    Naunyn Schmiedebergs Arch Pharmakol; 1971; 271(1):29-58. PubMed ID: 4256396
    [No Abstract]   [Full Text] [Related]  

  • 22. Reserpine-induced depletion of the norepinephrine stores: is it a reliable criterion for the classification of the mechanism of action of sympathomimetic amines?
    Luchelli-Fortis MA; Langer SZ
    J Pharmacol Exp Ther; 1974 Mar; 188(3):640-53. PubMed ID: 4816331
    [No Abstract]   [Full Text] [Related]  

  • 23. The effect of N-cycloalkylation on the cardiovascular activity of noradrenalone.
    Chang LC; Cobbin LB
    Arch Int Pharmacodyn Ther; 1972 Jun; 197(2):224-35. PubMed ID: 4113163
    [No Abstract]   [Full Text] [Related]  

  • 24. The degeneration contraction of a sympathetically innervated smooth muscle in the rat after reserpine, inhibition of monoamine oxidase or tyrosine hydroxylase.
    Lundberg D
    Acta Physiol Scand; 1970 Sep; 80(1):107-16. PubMed ID: 4394456
    [No Abstract]   [Full Text] [Related]  

  • 25. Stimulating effects of tolazoline on the nictitating membrane of the cat.
    Hoszowska-Owczarek A; Djordjevic N; Langer SZ; De Schaepdryver AF
    Arch Int Pharmacodyn Ther; 1967 Aug; 168(2):485-7. PubMed ID: 6049341
    [No Abstract]   [Full Text] [Related]  

  • 26. Interaction between some cheeses and monoamine oxydase inhibitors.
    Kayaalp SO; Kaymakçalan S; Ozer A
    Arzneimittelforschung; 1968 Sep; 18(9):1195-8. PubMed ID: 5756049
    [No Abstract]   [Full Text] [Related]  

  • 27. Central action of prostaglandin F2alpha on circulatory system in rats.
    Brus R; Zabawska J
    Pol J Pharmacol Pharm; 1976; 28(5):455-62. PubMed ID: 1012975
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antiarrhythmic effect of some naphthylalkylamine derivatives.
    Hadházy P; Kecskeméti V; Vizi ES; Illés P
    Acta Physiol Acad Sci Hung; 1968; 33(2):185-95. PubMed ID: 5679793
    [No Abstract]   [Full Text] [Related]  

  • 29. Development of degeneration contraction and supersensitivity in the cat's nictitating membrane after 6-hydroxydopamine.
    Wagner K; Trendelenburg U
    Naunyn Schmiedebergs Arch Pharmakol; 1971; 270(3):215-36. PubMed ID: 4254621
    [No Abstract]   [Full Text] [Related]  

  • 30. A new anorexic agent, WY-5244: cardiovascular actions and influence on sympathomimetic amines.
    Baum T; Gluckman MI
    J Pharmacol Exp Ther; 1967 Jul; 157(1):32-41. PubMed ID: 4382099
    [No Abstract]   [Full Text] [Related]  

  • 31. The possible role of brain monoamines in the acute toxicity of digitoxigenin.
    Buterbaugh GG; Spratt JL
    J Pharmacol Exp Ther; 1970 Oct; 175(1):121-30. PubMed ID: 4394300
    [No Abstract]   [Full Text] [Related]  

  • 32. Cardiovascular effects produced in cats by the chronic administration of small doses of reserpine.
    Withrington P; Zaimis E
    Cardiovasc Res; 1967 Jan; 1(1):52-62. PubMed ID: 6060161
    [No Abstract]   [Full Text] [Related]  

  • 33. Cardiovascular effects of 2-(2,6-dichlorophenylamino)-2-imidazoline hydrochloride (ST 155). I. Peripheral sympathetic system.
    Boissier JR; Giudicelli JF; Fichelle J; Schmitt H; Schmitt H
    Eur J Pharmacol; 1968 Mar; 2(5):333-9. PubMed ID: 5663498
    [No Abstract]   [Full Text] [Related]  

  • 34. Effects of chronic pretreatment with pargyline upon responses of the atrial pacemaker and of left atrial strips of guinea pigs to tyramine, mephentermine, d-amphetamine and adrenergic nerve stimulation.
    Antonaccio MJ; Smith CB
    J Pharmacol Exp Ther; 1969 Nov; 170(1):97-107. PubMed ID: 4900523
    [No Abstract]   [Full Text] [Related]  

  • 35. Catecholamine turnover in normotensive and hypertensive man: effects of antiadrenergic drugs.
    DeQuattro V; Sjoerdsma A
    J Clin Invest; 1968 Oct; 47(10):2359-73. PubMed ID: 5676529
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Adrenergic receptors on some organs.
    Takagi K; Osada E; Takayanagi I; Taga F
    Arch Int Pharmacodyn Ther; 1967 Jul; 168(1):212-9. PubMed ID: 4383015
    [No Abstract]   [Full Text] [Related]  

  • 37. Adrenergic mechanism of the drugs. Systemic arterial pressure changes caused by intravenous injection of reserpine following the administration of pheniprazine and pyrogallol in anesthetized dogs.
    Takasak K
    Kurume Med J; 1966; 13(3):99-111. PubMed ID: 4381259
    [No Abstract]   [Full Text] [Related]  

  • 38. [Apropos of various pharmacodynamic activities of pargyline in the rat and cat].
    Cession-Fossion A
    Arch Int Pharmacodyn Ther; 1966 Jun; 161(2):298-305. PubMed ID: 5926872
    [No Abstract]   [Full Text] [Related]  

  • 39. The actions of histamine on the mammalian heart.
    Flacke W; Atanacković D; Gillis RA; Alper MH
    J Pharmacol Exp Ther; 1967 Feb; 155(2):271-8. PubMed ID: 6025518
    [No Abstract]   [Full Text] [Related]  

  • 40. Modification of the cardiovascular response to isoproterenol by pilocarpine.
    Daniell HB; Bagwell EE
    Arch Int Pharmacodyn Ther; 1969 Sep; 181(1):141-52. PubMed ID: 5350777
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.